Disclosures: Richard Morrow: Nothing to Disclose, Dahn Jeong: Nothing to Disclose, Jean Makuza: Nothing to Disclose, Michael Irvine: Nothing to Disclose, Alnoor Ramji: Nothing to Disclose, Hin Hin Ko: Nothing to Disclose, Mel Krajden: Nothing to Disclose, Sofia Bartlett: Nothing to Disclose, Stanley Wong: Nothing to Disclose, Amanda Yu: Nothing to Disclose, JASON WONG: Nothing to Disclose, Julia Li: Nothing to Disclose, Naveed Janjua: Nothing to Disclose 381 HEPATITIS B TREATMENT OUTCOMES AND FACTORS ASSOCIATED WITH HBV TREATMENT SUCCESS: A POPULATION-BASED STUDY IN RWANDA Jean Damascene Makuza 1 Dahn Jeong 2 Atul Aravindakshan 3 Richard Morrow 3 Prince Adu 4 Marie Paul Nisingizwe 3 Georgine Cua 4 Hctor Velsquez Garca 4 Janvier Serumondo 5 Albert Tuyishime 5 Joseph Puyat 3 Joseph Puyat 3 Alnoor Ramji 2 Michael Law 3 Naveed Janjua 4 , 1 The University of British Columbia, SPPH, 2 University of British Columbia, 3 The University of British Columbia, 4 British Columbia Centre for Disease Control, 5 Rwanda Biomedical Centre Background: Timely treatment of chronic hepatitis B virus (HBV) infection reduces complications such as cirrhosis and hepatocellular carcinoma and improves overall survival

Kapoor M, Martel-Pelletier J, Lajeunesse D, Pelletier JP, Fahmi H
Rui et al., 2023)
Compatible with breastfeeding in standard therapeutic dosing
B12 should be kept out of the reach of children
Q1: Are VetPen needles reusable for multiple injections